NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
14 hedge funds and large institutions have $227K invested in NeuroMetrix, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
46% less capital invested
Capital invested by funds: $423K → $227K (-$196K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$22.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.63K |
| 3 |
Renaissance Technologies
New York
|
+$4.82K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.25K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$113K |
| 2 |
HF
HRT Financial
New York
|
-$25K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$705 |
NURO Hedge Fund Activity: Q3 2023 in Review
14 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2023, worth a combined $227K — down 46% from $423K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NURO positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $22.8K. The largest seller was Vanguard Group, cutting an estimated $113K.
- 14 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2023, up from 13 in Q2 2023.
- Funds reported $227K of NeuroMetrix, Inc. Common Stock stock for Q3 2023, down 46% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $22.8K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2023 was Vanguard Group, an estimated $113K sold.
Based on aggregated 13F filings for Q3 2023.